MiR-17-92 cluster has been suggested to function as oncomiRNA in MM, as members of this cluster were shown to target tumor suppressor genes such as the pro-apoptotic BIM [46, 47]. This evidence concerns the gene BCL2L11 and Miyoshi myopathy.